Investigate rates of Performance Validity Test (PVT) failures in a group of active duty (AD) military participants referred for ADHD evaluations and other characteristics of those referred for evaluation. AD service members referred for ADHD evaluations were given PVTs as part of assessment. PVT pass/fail groups were compared on age, estimated premorbid intelligence, history of ADHD, other mental health problems, and functional impairment. PVT failure rate was consistent with other studies. Fail group was younger and lower estimated premorbid intelligence than those that passed. Groups based on other variables did not significantly differ. Failure group also performed worse on a measure of attention. Many individuals were referred with no childhood history of ADHD or objective evidence of impaired function. Rates of PVT failures were similar to those found in civilian university and veteran military settings. Screening candidates for specific (5th ed.) criteria for ADHD was only minimally followed.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1087054719829576DOI Listing

Publication Analysis

Top Keywords

adhd evaluations
12
rates performance
8
performance validity
8
validity test
8
pvt failures
8
referred adhd
8
estimated premorbid
8
premorbid intelligence
8
history adhd
8
adhd
6

Similar Publications

This review examines the therapeutic potential of neuromodulation methods, including neurofeedback, transcranial direct current stimulation (tDCS), and transcranial magnetic stimulation (TMS), as non-pharmacological interventions for children with attention-deficit/hyperactivity disorder (ADHD). A comprehensive review of current studies was conducted, focusing on each technique's mechanism, application, and efficacy in managing ADHD symptoms and cognitive deficits. Studies included human participants with ADHD, evaluating changes in symptom severity and cognitive outcomes.

View Article and Find Full Text PDF

Objectives: This study investigated the relationship between exposure to endocrine-disrupting chemicals (EDCs), specifically phthalates, bisphenol A, bisphenol F, and bisphenol S, and the severity of attention-deficit/hyperactivity disorder (ADHD) symptoms using neuropsychological tests in children diagnosed with ADHD.

Methods: This study included 67 medication-naïve children with ADHD aged 6-16 years. The urinary concentrations of EDCs were measured, and ADHD symptom severity was evaluated using neuropsychological tests and clinical symptom scale measurements.

View Article and Find Full Text PDF

Background: Attention Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder which poses challenges for the individuals with the disorder and their families. While stimulant medications are effective, a comprehensive approach, including psychosocial and behavioral interventions, is recommended. There is a growing body of research exploring the potential benefits of mindfulness-based interventions for children with ADHD.

View Article and Find Full Text PDF

The current paper aimed to estimate the network structure of general psychopathology (internalizing and externalizing symptoms/disorders) among 239 gifted children in Jordan. This cross-sectional study with a convenience sampling method was conducted between September 2023 and October 2024 among gifted children aged 7-12. The Child Behavior Checklist (CBCL) was employed to assess six symptom clusters: conduct problems, attention-deficit/hyperactivity disorder (ADHD), and oppositional defiant problems as externalizing symptoms, and affective problems, anxiety issues, and somatic complaints as internalizing symptoms.

View Article and Find Full Text PDF

Background: Metoclopramide, a dopamine antagonist employed for its antiemetic effects, can precipitate neuropsychiatric adverse effects, including extrapyramidal symptoms and, in a few instances, acute psychosis. Although there have been reports of metoclopramide-induced psychosis in elderly individuals, there is no documentation of such incidents in children as far as we are aware.

Case Presentation: This case report describes an 11-year-old girl with a history of mild intellectual disability and attention deficit hyperactivity disorder, managed with 10 mg of methylphenidate daily.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!